Sentence examples for this may currently from inspiring English sources

Consequently, most of the remaining questions are those for which one has given up in looking for solutions; this may currently be the biggest problem for biological research.

However, this may currently be impractical due to storage and economic considerations, although we expect that this approach could become much more plausible in the future.

23 This may currently be counteracted by differing advice from primary and secondary care practitioners and emphasises the need for greater awareness of guidelines, but there is also a need for further clinical trials in terms of medical treatment to underpin this.

However, while the limitations of this study are important to acknowledge, this methodology may currently be the only way to examine individuals who have moved, in some cases, from relative poverty to extreme affluence and who have followings larger than the population of entire countries.

In Malawi, there has recently been significant CCM program expansion, but the last DHS predated this, so it does not reflect whatever relative contribution this program may currently be making.

This conflict may currently exist because many previously published assessments may not have effectively connected design layout with the level of biological relative to technical replication.

In Sweden, there has been little civic conditioning in family migration policy, though this situation may currently be changing due to the large influx of asylum migrants (more than 160 000 asylum seekers during 2015).

This situation may currently be the most relevant.

Practical applications of this method may currently be constrained by the overall duration of the procedures (∼24 hr total), and by the low yield of monodisperse vesicles.

This approach may currently be financially infeasible with the large samples required to detect the modest genetic effects we expect for complex traits, particularly for rare variant associations.

This 'alternative' universe may currently seem a long way off: a vibrant clinical-trial culture, public-private partnerships, pathogenetic- and structure-led drug design, efficient drug development pipelines, biomarker-defined treatment protocols enabling personalization of medicine, and a bench-to-approval transit time of less than ten years.